You are about to leave jnjmedicaldevices.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Features & Benefits
-
A minimally‐invasive option for nasal obstruction
The RELIEVA TRACT® Nasal Dilation System is an instrument intended to provide increased intranasal space to facilitate access for endonasal and transnasal procedures and/or temporarily address nasal obstruction by displacing the inferior turbinate and lower nasal septum.1
Supporting Documentation
Product Brochure
RELIEVA TRACT® Nasal Dilation System Brochure
Product Size | Product Size | Unit Count | Catalog Code |
---|---|---|---|
10x40mm | 10x40mm | 5PK | RT1040A |
10x40mm | 10x40mm | 1PK | RT1040AZ |
12x40mm | 12x40mm | 5PK | RT1240A |
12x40mm | 12x40mm | 1PK | RT1240AZ |
14x40mm | 14x40mm | 5PK | RT1440A |
14x40mm | 14x40mm | 1PK | RT1440AZ |
16x40mm | 16x40mm | 5PK | RT1640A |
16x40mm | 16x40mm | 1PK | RT1640AZ |
References
1. IFU005161 Rev A RELIEVA TRACT® Balloon Dilation System ‐ Instructions for Use
Disclosures
Important Safety Information
The RELIEVA TRACT® Nasal Balloon Dilation System is an instrument intended to provide increased intranasal space to facilitate access for endonasal and transnasal procedures and/or temporarily address nasal obstruction by displacing the inferior turbinate and lower nasal septum. The RELIEVA TRACT® Nasal Balloon Dilation System is intended for use in ages 17 years or older.
Balloon dilation catheters should be used by or under supervision of physicians thoroughly trained in balloon dilation. A thorough understanding of the technical principles, clinical application, and risk associated with balloon dilation of the nasal passage is necessary before using this device.
Third party trademarks used herein are trademarks of their respective owners. This content is intended for audience within the US only.
119300-190724
Important information: Prior to use, refer to the instructions for use supplied with this device for indications, contraindications, side effects, warnings and precautions.
This site is published by Acclarent, Inc. which is solely responsible for its contents. It is intended for visitors from the United States.
© Acclarent, Inc. 2020. Last Updated on 09/30/2020